BioAge Labs, Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -14.6% | -19.5% | +48.5% | -22.4% | +23.7% | -21.3% | +56.8% | -15.5% | +40.8% | -8.7% | +11.1% | – | |
| – | +1.3% | +11.1% | +82.9% | +18.6% | +47.2% | +8.4% | +9.5% | -13.6% | -2.5% | +56.4% | +0.3% | – | |
| – | +250.7% | -203.8% | – | – | +118.0% | -155.5% | – | – | -404.5% | – | – | – | |
| – | -100.0% | – | – | +771.4% | -91.5% | +1,538.5% | -62.7% | -86.2% | +409.1% | -76.8% | +1,161.5% | – | |
| – | – | – | – | +771.4% | -91.5% | +299,853.8% | -79.9% | – | -212.4% | +224.0% | +251.9% | – | |
| – | – | – | – | – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | -22.7% | – | |
| – | +2,302.4% | – | -101.4% | – | -86.9% | -106.0% | +0.0% | +2.9% | – | +672.6% | -87.1% | – | |
| – | – | – | -112.0% | – | -88.7% | -587.4% | – | – | – | – | -417.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.